Travere Therapeutics, Inc.
TVTX
37 insider filings · Latest: May 5, 2026
Common Stock Transactions
| Txn Date | Accepted | Insider | Type | Shares | Avg Price | Value | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|---|
| Dec 24, 2025 | Dec 29 11:28 AM | ROTE WILLIAM E. | Proposed Sale | 60,000 | $40.10 | $2.4M | — | View → |
| Dec 15, 2025 | Dec 15 9:05 PM | SANDRA CALVIN | Proposed Sale | 2,910 | $36.00 | $104.8K | — | View → |
| Dec 1, 2025 | Dec 1 9:09 PM | CHRISTOPHER CLINE | Proposed Sale | 20,000 | $35.01 | $700.2K | — | View → |
| Nov 4, 2025 | Nov 4 9:14 PM | SANDRA CALVIN | Proposed Sale | 67,115 | $36.00 | $2.4M | — | View → |
| Oct 31, 2025 | Oct 31 8:05 PM | Coughlin Timothy | Proposed Sale | 18,000 | $34.98 | $629.7K | — | View → |
| Oct 31, 2025 | Oct 31 6:51 PM | Heerma Peter | Proposed Sale | 5,591 | $35.00 | $195.7K | — | View → |
| Oct 29, 2025 | Oct 29 8:26 PM | Dube Eric M | Proposed Sale | 27,128 | $30.12 | $817.0K | — | View → |
| Oct 28, 2025 | Oct 28 8:57 PM | Dube Eric M | Proposed Sale | 92,872 | $30.38 | $2.8M | — | View → |
| Oct 28, 2025 | Oct 28 6:08 PM | Heerma Peter | Proposed Sale | 2,662 | $30.00 | $79.9K | — | View → |
| Sep 22, 2025 | Sep 22 8:02 PM | ELIZABETH REED | Proposed Sale | 10,000 | $25.00 | $250.0K | — | View → |
| May 5, 2025 | May 5 11:45 PM | Christopher Cline | Proposed Sale | 1,784 | $21.05 | $37.6K | — | View → |
| May 5, 2025 | May 5 11:41 PM | Peter Heerma | Proposed Sale | 1,771 | $21.05 | $37.3K | — | View → |
| May 5, 2025 | May 5 3:32 PM | REED ELIZABETH E | Proposed Sale | 4,920 | $21.05 | $103.6K | — | View → |
| May 5, 2025 | May 5 3:20 PM | Dube Eric M | Proposed Sale | 18,924 | $21.05 | $398.4K | — | View → |
| May 5, 2025 | May 5 2:08 PM | ROTE WILLIAM E. | Proposed Sale | 3,198 | $21.05 | $67.3K | — | View → |
| Apr 11, 2025 | Apr 11 11:03 PM | Christopher Cline | Proposed Sale | 48 | $13.14 | $631 | — | View → |
| Feb 12, 2025 | Feb 13 12:47 AM | Peter Heerma | Proposed Sale | 2,568 | $23.53 | $60.4K | — | View → |
| Feb 12, 2025 | Feb 13 12:46 AM | Jula Inrig | Proposed Sale | 2,568 | $23.53 | $60.4K | — | View → |
| Feb 12, 2025 | Feb 12 4:03 PM | ROTE WILLIAM E. | Proposed Sale | 5,200 | $23.53 | $122.4K | — | View → |
| Feb 12, 2025 | Feb 12 2:52 PM | REED ELIZABETH E | Proposed Sale | 8,000 | $23.53 | $188.2K | — | View → |
Stock Options & Derivatives
| Txn Date | Accepted | Insider | Type | Shares | Exercise Price | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|
| May 5, 2026 | May 7 12:00 AM | Roy D. BaynesDirector | Option Exercise | 4,500 | $18.27 | 0(D) | View → |
| May 4, 2026 | May 7 12:00 AM | Meckler Jeffrey ADirector | Option Exercise | 8,000 | $16.33 | 0(D) | View → |
| May 4, 2026 | May 7 12:00 AM | William E. RoteChief Research Officer | Grant/Award | 8,500 | — | 8,500(D) | View → |
| May 4, 2026 | May 7 12:00 AM | William E. RoteChief Research Officer | Option Exercise | 4,250 | — | 4,250(D) | View → |
| May 4, 2026 | May 7 12:00 AM | Elizabeth E ReedChief Legal Officer and GC | Grant/Award | 8,500 | — | 8,500(D) | View → |
| May 4, 2026 | May 7 12:00 AM | Elizabeth E ReedChief Legal Officer and GC | Option Exercise | 24,250 | $17.96 | 4,250(D) | View → |
| May 4, 2026 | May 7 12:00 AM | Jula InrigCHIEF MEDICAL OFFICER | Grant/Award | 8,500 | — | 8,500(D) | View → |
| May 4, 2026 | May 7 12:00 AM | Jula InrigCHIEF MEDICAL OFFICER | Option Exercise | 24,250 | $22.40 | 4,250(D) | View → |
| May 4, 2026 | May 7 12:00 AM | Peter HeermaCHIEF COMMERCIAL OFFICER | Grant/Award | 8,500 | — | 8,500(D) | View → |
| May 4, 2026 | May 7 12:00 AM | Peter HeermaCHIEF COMMERCIAL OFFICER | Option Exercise | 4,250 | — | 4,250(D) | View → |
| May 4, 2026 | May 7 12:00 AM | Eric M DubeDirector, CHIEF EXECUTIVE OFFICER | Grant/Award | 45,000 | — | 45,000(D) | View → |
| May 4, 2026 | May 7 12:00 AM | Eric M DubeDirector, CHIEF EXECUTIVE OFFICER | Option Exercise | 22,500 | — | 22,500(D) | View → |
| May 4, 2026 | May 7 12:00 AM | Christopher R. ClineCHIEF FINANCIAL OFFICER | Option Exercise | 4,250 | — | 4,250(D) | View → |
| May 4, 2026 | May 7 12:00 AM | Christopher R. ClineCHIEF FINANCIAL OFFICER | Grant/Award | 8,500 | — | 8,500(D) | View → |
| May 1, 2026 | May 4 8:27 PM | Roy D. BaynesDirector | Option Exercise | 9,750 | $6.82 | 9,750(D) | View → |
| Apr 14, 2026 | Apr 16 8:05 PM | LYONS GARY ADirector | Option Exercise | 8,000 | $16.33 | 0(D) | View → |
| Apr 14, 2026 | Apr 16 8:05 PM | Roy D. BaynesDirector | Option Exercise | 32,750 | $21.38 | 6,750(D) | View → |
| Apr 14, 2026 | Apr 16 8:05 PM | Sandra CalvinSVP, CHIEF ACCOUNTING OFFICER | Option Exercise | 15,250 | $22.40 | 19,500(D) | View → |
| Apr 14, 2026 | Apr 16 1:47 AM | Elizabeth E ReedChief Legal Officer and GC | Option Exercise | 37,500 | $19.08 | 20,000(D) | View → |
| Apr 6, 2026 | Apr 7 10:17 PM | Roy D. BaynesDirector | Option Exercise | 10,000 | $26.52 | 0(D) | View → |
Page 1 of 2
Next →